Vinciane Rebours

8.9k total citations · 2 hit papers
160 papers, 4.4k citations indexed

About

Vinciane Rebours is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Vinciane Rebours has authored 160 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Oncology, 101 papers in Surgery and 64 papers in Epidemiology. Recurrent topics in Vinciane Rebours's work include Pancreatic and Hepatic Oncology Research (89 papers), Pancreatitis Pathology and Treatment (76 papers) and Neuroendocrine Tumor Research Advances (50 papers). Vinciane Rebours is often cited by papers focused on Pancreatic and Hepatic Oncology Research (89 papers), Pancreatitis Pathology and Treatment (76 papers) and Neuroendocrine Tumor Research Advances (50 papers). Vinciane Rebours collaborates with scholars based in France, United Kingdom and United States. Vinciane Rebours's co-authors include Philippe Ruszniewski, Philippe Lévy, Anne Couvelard, Pascal Hammel, Alain Sauvanet, Olivia Hentic, Frédérique Maire, Marie‐Pierre Vullierme, Sébastien Gaujoux and Pierre Bédossa and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Vinciane Rebours

142 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chronic pancreatitis

2017 300 citations Jörg Kleeff, David C. Whitcomb et al. Nature Reviews Disease Primers profile →
Gastrointestinal pain

2020 174 citations Asbjørn Mohr Drewes, Vinciane Rebours et al. Nature Reviews Disease Primers profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vinciane Rebours France	36	2.8k	2.4k	1.4k	587	521	160	4.4k
Vincenzo Ziparo Italy	31	1.5k 0.5×	1.4k 0.6×	1.0k 0.7×	571 1.0×	380 0.7×	126	3.3k
Robert Birch United States	33	1.7k 0.6×	1.8k 0.7×	428 0.3×	959 1.6×	660 1.3×	107	5.0k
Åke Andrén‐Sandberg Sweden	42	3.9k 1.4×	3.7k 1.5×	1.2k 0.9×	1.3k 2.1×	118 0.2×	204	6.3k
Naohiro Sata Japan	32	2.0k 0.7×	1.9k 0.8×	726 0.5×	1.3k 2.3×	114 0.2×	308	4.3k
Per Hellman Sweden	52	2.8k 1.0×	2.3k 0.9×	2.8k 2.0×	646 1.1×	1.7k 3.3×	195	8.3k
Yu‐Wen Tien Taiwan	31	1.4k 0.5×	1.2k 0.5×	436 0.3×	503 0.9×	73 0.1×	144	2.9k
S. Villà Spain	35	1.5k 0.5×	781 0.3×	1.4k 1.0×	3.1k 5.3×	1.0k 2.0×	122	5.6k
Johannes M.G. Bonfrèr Netherlands	33	1.4k 0.5×	467 0.2×	757 0.5×	994 1.7×	400 0.8×	67	4.1k
Tanya Surawicz United States	20	1.0k 0.4×	600 0.2×	698 0.5×	736 1.3×	430 0.8×	39	3.4k
Klaus‐Martin Schulte Germany	30	844 0.3×	886 0.4×	486 0.3×	325 0.6×	140 0.3×	147	3.1k

Countries citing papers authored by Vinciane Rebours

Since Specialization

Citations

This map shows the geographic impact of Vinciane Rebours's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinciane Rebours with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinciane Rebours more than expected).

Fields of papers citing papers by Vinciane Rebours

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vinciane Rebours. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinciane Rebours. The network helps show where Vinciane Rebours may publish in the future.

Co-authorship network of co-authors of Vinciane Rebours

This figure shows the co-authorship network connecting the top 25 collaborators of Vinciane Rebours. A scholar is included among the top collaborators of Vinciane Rebours based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vinciane Rebours. Vinciane Rebours is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vullierme, Marie‐Pierre, Christophe Desterke, Sophie Hillaire, et al.. (2025). Primary intrahepatic lithiasis in western countries: role of ultrasound and comparison with MRI with MRCP. European Journal of Gastroenterology & Hepatology. 37(9). 1078–1087.

Raffenne, Jérôme, Rémy Nicolle, Miguel Albuquerque, et al.. (2025). Protective role of oleic acid against palmitic acid-induced pancreatic fibrosis. Journal of Translational Medicine. 23(1). 416–416. 2 indexed citations

Dokmak, Safi, Béatrice Aussilhou, Louis de Mestier, et al.. (2025). Distal pancreatectomy with celiac axis resection (DP-CAR) for pancreatic ductal adenocarcinoma in a retrospective monocentric cohort: neoadjuvant treatment and three-axis embolization of the celiac axis are key factors of success. HPB. 27(8). 1048–1059. 1 indexed citations

Sokal, Aurélien, Safi Dokmak, Audrey Le Bot, et al.. (2025). Recurrent Nonobstructive Cholangitis After Pancreaticoduodenectomy: Prevalence, Risk Factors, and Treatment. World Journal of Surgery. 49(9). 2570–2577. 1 indexed citations

Grégory, Jules, Frédéric Bert, Anna Pellat, et al.. (2024). Diagnosis and treatment of bacterial peritonitis in patients with gastrointestinal cancer: an observational multicenter study. Therapeutic Advances in Medical Oncology. 16. 12703176–12703176.

Aussilhou, Béatrice, Fadhel Samir Ftériche, Louis de Mestier, et al.. (2024). Outcome and survival were similar with laparoscopic and open pancreatectomy in 102 solid pseudopapillary neoplasms. Surgical Endoscopy. 38(4). 2169–2179. 1 indexed citations

Laouali, Nasser, et al.. (2023). Childhood and adulthood passive and active smoking, and the ABO group as risk factors for pancreatic cancer in women. United European Gastroenterology Journal. 12(4). 440–450. 3 indexed citations

Cros, Jérôme, Jean‐Luc Van Laethem, Jean‐François Emile, et al.. (2023). Trop-2 is a ubiquitous and promising target in pancreatic adenocarcinoma. Clinics and Research in Hepatology and Gastroenterology. 47(4). 102108–102108. 7 indexed citations

de‐Madaria, Enrique, et al.. (2023). A protocol for an international, multicenter, prospective, non-interventional observational registry for patients with hypertriglyceridemia. Current Medical Research and Opinion. 39(12). 1663–1670. 1 indexed citations

10.

Masson, Emmanuelle, Jian‐Min Chen, Claude Férec, et al.. (2023). Genetic and functional analysis of chymotrypsin-like protease (CTRL) in chronic pancreatitis. Pancreatology. 23(8). 957–963. 2 indexed citations

11.

Neuzillet, Cindy, Rémy Nicolle, Jérôme Raffenne, et al.. (2022). Periostin‐ and podoplanin‐positive cancer‐associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma. The Journal of Pathology. 258(4). 408–425. 33 indexed citations

12.

Perrier, Marine, Olivia Hentic, Hédia Brixi, et al.. (2022). FOLFOX ‐bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors. Journal of Neuroendocrinology. 35(1). e13227–e13227. 8 indexed citations

13.

Michl, Patrick, Matthias Löhr, John P. Neoptolemos, et al.. (2021). UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better. United European Gastroenterology Journal. 9(7). 860–871. 37 indexed citations

14.

Canaff, Lucie, Emmanuelle Masson, Jian‐Min Chen, et al.. (2021). The three common polymorphisms p.A986S, p.R990G and p.Q1011E in the calcium sensing receptor (CASR) are not associated with chronic pancreatitis. Pancreatology. 21(7). 1299–1304. 3 indexed citations

15.

Korenbaum, Clément, Chrystelle Colas, Florence Coulet, et al.. (2019). Familial pancreatic adenocarcinoma: A retrospective analysis of germline genetic testing in a French multicentre cohort. Clinical Genetics. 96(6). 579–584. 5 indexed citations

16.

Mestier, Louis de, Jérôme Cros, Olivia Hentic, et al.. (2019). Lesion-by-lesion correlation between uptake at FDG PET and the Ki67 proliferation index in resected pancreatic neuroendocrine tumors. Digestive and Liver Disease. 51(12). 1720–1724. 16 indexed citations

17.

Kleeff, Jörg, David C. Whitcomb, Tooru Shimosegawa, et al.. (2017). Chronic pancreatitis. Nature Reviews Disease Primers. 3(1). 17060–17060. 300 indexed citations breakdown →

18.

Maire, Frédérique, Vinciane Rebours, Marie‐Pierre Vullierme, et al.. (2014). Does tobacco influence the natural history of autoimmune pancreatitis?. Pancreatology. 14(4). 284–288. 16 indexed citations

19.

Handra‐Luca, Adriana, Claude Lesty, Pascal Hammel, et al.. (2011). Biological and Prognostic Relevance of Mitogen-Activated Protein Kinases in Pancreatic Adenocarcinoma. Pancreas. 41(3). 416–421. 28 indexed citations

20.

Rebours, Vinciane, Philippe Lévy, Pascal Hammel, Olivier Farges, & Philippe Ruszniewski. (2005). Cholangiocarcinome secondaire à une cholangite radique associée à une pancréatite chronique radique. Gastroentérologie Clinique et Biologique. 29(6-7). 732–734. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact